We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $2.07B
1-Year Est. Return 157.17%
This Fund
S&P 500
This Quarter Est. Return
-23.03%
1 Year Est. Return
+157.17%
3 Year Est. Return
+781.63%
5 Year Est. Return
+899.06%
10 Year Est. Return
AUM
$1.13B
AUM Growth
-$171M
Cap. Flow
+$169M
Cap. Flow %
14.91%
Top 10 Hldgs %
69.03%
Holding
192
New
49
Increased
49
Reduced
52
Closed
35

Top Buys

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$58.8M
2
OPEN icon
Opendoor
OPEN
+$51.8M
3
SIVB
SVB Financial Group
SIVB
+$33.4M
4
ABNB icon
Airbnb
ABNB
+$27.8M
5
ASAN icon
Asana
ASAN
+$19.7M

Sector Composition

Rank Sector Weight
1 Financials 39.15%
2 Technology 19.05%
3 Real Estate 13.52%
4 Consumer Discretionary 9.09%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGN icon
101
CALL
Align Technology
ALGN
$12.7B
$131K 0.01%
+300
New +$146K
MRUS
102
DELISTED
Merus
MRUS
$121K 0.01%
+4,561
New +$122K
GRTX
103
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$119K 0.01%
+50,000
New +$130K
JSPR icon
104
Jasper Therapeutics
JSPR
$24.8M
$107K 0.01%
+3,000
New +$135K
KPTI icon
105
Karyopharm Therapeutics
KPTI
$216M
$95.8K 0.01%
+867
New +$108K
ASND icon
106
Ascendis Pharma A/S
ASND
$17.1B
$93.9K 0.01%
+800
New +$92.7K
KROS icon
107
Keros Therapeutics
KROS
$211M
$92.4K 0.01%
+1,700
New +$87.3K
CCCC icon
108
C4 Therapeutics
CCCC
$408M
$92.2K 0.01%
+3,800
New +$92.3K
YMAB
109
DELISTED
Y-mAbs Therapeutics
YMAB
$83.2K 0.01%
+7,000
New +$71.9K
DOCS icon
110
CALL
Doximity
DOCS
$3.87B
$78.1K 0.01%
+1,500
New +$75.5K
VSTM icon
111
Verastem
VSTM
$530M
$70.5K 0.01%
+4,167
New +$71.7K
SYRE icon
112
Spyre Therapeutics
SYRE
$8.7B
$57.5K 0.01%
1,000
ZNGA
113
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$56.3K 0.01%
6,091
+561
+10% +$4.93K
PRVB
114
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$54.9K ﹤0.01%
+7,500
New +$44.9K
SPGI icon
115
S&P Global
SPGI
$133B
$52.5K ﹤0.01%
128
+64
+100% +$26.1K
V icon
116
Visa
V
$682B
$49.2K ﹤0.01%
222
-3,548
-94% -$767K
COF icon
117
Capital One
COF
$128B
$48.1K ﹤0.01%
366
+123
+51% +$17.9K
GNCA
118
DELISTED
Genocea Biosciences, Inc.
GNCA
$43.8K ﹤0.01%
+35,000
New +$38.1K
NKE icon
119
Nike
NKE
$64.9B
$43.6K ﹤0.01%
324
+148
+84% +$20.8K
AAPL icon
120
Apple
AAPL
$4.9T
$42.3K ﹤0.01%
242
-9,903
-98% -$1.67M
GTHX
121
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$38K ﹤0.01%
+5,000
New +$47.4K
ISO
122
DELISTED
IsoPlexis Corporation Common Stock
ISO
$36.3K ﹤0.01%
+10,572
New +$61.2K
IT icon
123
Gartner
IT
$9.39B
$35.1K ﹤0.01%
118
+39
+49% +$11.3K
LULU icon
124
lululemon athletica
LULU
$13.2B
$34K ﹤0.01%
93
+36
+63% +$11.7K
ISRG icon
125
Intuitive Surgical
ISRG
$122B
$32.9K ﹤0.01%
109
-3,333
-97% -$974K

Similar funds

BIT Capital's Q1 2022 Portfolio in Review

As of Q1 2022, BIT Capital held 192 positions worth $1.13B, down 13% from $1.3B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

BIT Capital deployed $169M of net new capital in Q1 2022, opening 49 new positions and adding to 49 existing holdings. Its largest new stake was Duolingo: 651,573 shares worth $62M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 48% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Qfin Holdings, an estimated $37.8M trimmed.

  • BIT Capital's largest Q1 2022 buy was Duolingo: 651,573 shares worth $62M.
  • BIT Capital added most to Opendoor in Q1 2022, an estimated $51.8M increase.
  • BIT Capital's biggest Q1 2022 reduction was Qfin Holdings, cutting an estimated $37.8M.
  • BIT Capital fully exited Alphabet (Google) Class C in Q1 2022, selling an estimated $13.2M.
  • BIT Capital's ten largest holdings make up 69% of its $1.13B portfolio in Q1 2022.
  • BIT Capital opened 49 new positions and closed 35 in Q1 2022.
  • BIT Capital's portfolio value fell 13% quarter-over-quarter to $1.13B.

Based on BIT Capital's 13F filing for Q1 2022, filed 12 Feb 2025.